Literature DB >> 9164814

Cancer undefeated.

J C Bailar1, H L Gornik.   

Abstract

BACKGROUND: Despite decades of basic and clinical research and trials of promising new therapies, cancer remains a major cause of morbidity and mortality. We assessed overall progress against cancer in the United States from 1970 through 1994 by analyzing changes in age-adjusted mortality rates.
METHODS: We obtained from the National Center for Health Statistics data on all deaths from cancer and from cancer at specific sites, as well as on deaths due to cancer according to age, race, and sex, for the years 1970 through 1994. We computed age-specific mortality rates and adjusted them to the age distribution of the U.S. population in 1990.
RESULTS: Age-adjusted mortality due to cancer in 1994 (200.9 per 100,000 population) was 6.0 percent higher than the rate in 1970 (189.6 per 100,000). After decades of steady increases, the age-adjusted mortality due to all malignant neoplasms plateaued, then decreased by 1.0 percent from 1991 to 1994. The decline in mortality due to cancer was greatest among black males and among persons under 55 years of age. Mortality among white males 55 or older has also declined recently. These trends reflect a combination of changes in death rates from specific types of cancer, with important declines due to reduced cigarette smoking and improved screening and a mixture of increases and decreases in the incidence of types of cancer not closely related to tobacco use.
CONCLUSIONS: The war against cancer is far from over. Observed changes in mortality due to cancer primarily reflect changing incidence or early detection. The effect of new treatments for cancer on mortality has been largely disappointing. The most promising approach to the control of cancer is a national commitment to prevention, with a concomitant rebalancing of the focus and funding of research.

Entities:  

Mesh:

Year:  1997        PMID: 9164814     DOI: 10.1056/NEJM199705293362206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  61 in total

Review 1.  Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

Authors:  A J Hayes; L Y Li; M E Lippman
Journal:  BMJ       Date:  1999-03-27

2.  Tumor immunotherapy: inching toward the finish line.

Authors:  Tyler J Curiel; David T Curiel
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Efficacy, safety, and cost of new anticancer drugs.

Authors:  Silvio Garattini; Vittorio Bertele
Journal:  BMJ       Date:  2002-08-03

4.  Progress against cancer (1971-2011): how far have we come?

Authors:  A K Tiwari; H K Roy
Journal:  J Intern Med       Date:  2011-10-20       Impact factor: 8.989

5.  Cancer: it's time to change the sign.

Authors:  James Downar
Journal:  CMAJ       Date:  2010-09-13       Impact factor: 8.262

6.  Age-period-cohort analysis of cancers not related to tobacco, screening, or HIV: sex and race differences.

Authors:  Yueh-Ying Han; Gregg E Dinse; David M Umbach; Devra L Davis; Joel L Weissfeld
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Appraising the economic efficiency of cancer treatment: an exploratory analysis of lung cancer.

Authors:  Thomas N Chirikos
Journal:  Health Care Manag Sci       Date:  2003-05

9.  The big cities health inventory, 1997.

Authors:  N Benbow; Y Wang; S Whitman
Journal:  J Community Health       Date:  1998-12

Review 10.  Factors in improved survival from paediatric cancer.

Authors:  J W Taub
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.